SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Edge who wrote (1943)6/11/1997 11:00:00 PM
From: Tunica Albuginea   of 3991
 
James , you are factually wrong; I have in my hands a copy of Lutts'
May 17' 1996 letter No.831.( get a copy from your library ) On p.2
he quotes his portfolio:

original current profit
date /purchase price
price

Presstek 7/6/94 13 163 1154%
Iomega 1/26/96 17 67 305%
MRV com. 5/15/96 51 51 -1%
Ascend 5/3 /95 10 65 572%
Zoltek 3/29/96 33 79 142%
Employee
Solutions 1/5/96 19 33 72%
America
on Line 10/13/95 33 58 76%
Corr.Corp.
of Amer. 10/13/95 38 68 82%
Netscape
Comm 5/15/96 71 70 -1%

ALL the above are ALL the stocks he includes in what he called
his Model Portfolio ( ie his MOST PROMISING stocks that he STRONGLY
reccommended be include in your own portfolio.

WARNING ( boiler plate type ): None of the above is to be construed
as an indication that TUNA supports Lutts' portfolio past , present or
future;the above are purely for entertainment purposes.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News